Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 USD | -6.03% | +13.33% | -80.94% |
Evolution of the average Target Price on Pacific Biosciences of California, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Pacific Biosciences of California, Inc.
JPMorgan Chase | |
Scotiabank | |
Goldman Sachs | |
TD Cowen | |
UBS | |
Guggenheim | |
Piper Sandler | |
Cantor Fitzgerald | |
Morgan Stanley | |
Barclays | |
Bernstein | |
Canaccord Genuity | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- PACB Stock
- Consensus Pacific Biosciences of California, Inc.